Intrinsic Value of S&P & Nasdaq Contact Us

Amicus Therapeutics, Inc. FOLD

NASDAQ Global Market

SharesGrow Score
45/100
1/7 Pass
SharesGrow Intrinsic Value
$62.51
+332.3%
Analyst Price Target
$14.50
+0.3%

Amicus Therapeutics, Inc. (FOLD) current share price is $14.46. The gold spot price is $4,808.10 per troy ounce. Using the formula: FOLD in gold = $14.46 × 31.1035 ÷ $4,808.10 = 0.0935 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of FOLD when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding FOLD shares over the measured period.

FOLD in US Dollars
Gold in US Dollars
FOLD in Gold (grams per share)

Real Wealth Growth Rate

FOLD
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{FOLD}_{\text{gold}}(t) = \frac{P_{\text{FOLD}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{FOLD}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{FOLD}_{\text{gold}}^{(T)}}{\text{FOLD}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{FOLD}_\text{gold}^{(0)}$ = initial gold-price, $\text{FOLD}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

ARGX
ARGX
argenx SE
$828.35
+2.36%
RVMD
RVMD
Revolution Medicines, Inc.
$147.01
+7.86%
INCY
INCY
Incyte Corporation
$97.69
+2.24%
KRTX
KRTX
Karuna Therapeutics, Inc.
$329.83
+0.03%
BMRN
BMRN
BioMarin Pharmaceutical Inc.
$55.47
+1.08%
BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
CYTK
CYTK
Cytokinetics, Incorporated
$66.35
-0.55%
CRNX
CRNX
Crinetics Pharmaceuticals, Inc.
$39.75
+2.82%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message